Purchase Order N0025919P0334
Award Date 6/17/19
Potential Completion Date 6/30/24
Potential Value $81K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Onalaska, WI 54650, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $95.7K firm fixed-price purchase order to Allergychoices LLC, a small disadvantaged business based in Onalaska, Wisconsin, for inhalant multi-allergen supplies. The contract, awarded on September 4, 2024, will run through September 30, 2029, and represents a sole-source procurement for sublingual immunotherapy (SLIT) consumables required to support U.S. Naval Hospital Yokosuka in Japan. Allergychoices was determined to be the only vendor capable of meeting the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Allergy Relief 180 mg tablets, with a total ceiling value of $1,730.40 and a period of performance through January 21, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $49,732.62 to Phadia US Inc.'s Immunodiagnostics Division on December 4, 2025, for allergy testing services that provide critical information in the detection and management of allergic reactions. The contract, which is set to be completed by September 30, 2026, will be performed in Portage, Michigan. As a subsidiary of Thermo Fisher Scientific specializing in advanced allergy and autoimmune...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,252.80, is for the supply of Allergy Relief 180 mg tablets. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $42,202 delivery order to AmerisourceBergen Drug Corp for Xolair 150 mg/ml syringes, a specialty pharmaceutical product used in the treatment of moderate-to-severe allergic asthma and chronic idiopathic urticaria. Issued on April 29, 2025, with an ultimate completion date of May 20, 2025, this firm fixed-price delivery order represents a non-competitive award under the company's larger indefinite delivery vehicle. The contract will...
- The Defense Health Agency awarded a $373,592.14 firm fixed-price delivery order to Greer Laboratories, Inc. (doing business as Stallergenes Greer) on September 27, 2024, for the supply of allergen reagents. The delivery order, with a completion date of September 30, 2024, represents a task order under one of the company's two significant indefinite delivery contracts with the Defense Health Agency. This delivery order will be performed at Fort Meade, Maryland, home of the U.S. Army Centralized...
- The Defense Logistics Agency awarded a $3,188.32 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Xolair 300 mg/2 mL auto-injector units. The contract is classified as firm fixed price with no set-aside designation, indicating the award resulted from open competition. Performance will be completed by July 14, 2025, with fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under...
- This delivery order, awarded July 31, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides XOLAIR 150 mg/1.2 mL powder for vials with a ceiling value of $15,850.75. The contract carries a firm fixed price structure with no set-aside designation and is scheduled for completion by August 21, 2025. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a competitive award under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $20.79K delivery order on August 6, 2025, for Xolair 300 mg/2 mL syringes, with completion expected by August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania headquarters. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99M prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed price delivery order, valued at $3,188.32, represents a non-competitive set-aside award and is scheduled for completion by August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Xolair is a biologic immunosuppressant...